• O1 Network
    • Articles
    • For Residents
    • For Medical Students
    • PORT Notes
    • MSK Medicine
    • Tumor Library
    • Cases
    • Talks
    • Images
    • Viewpoints
    • Question Bank
    • Devices
    • Residency
    • Fellowships
    • Associations
    • Companies
ORTHOPAEDICSONE ARTICLES
OrthopaedicsOne Articles
  • Articles
    • Specialty
      • Arthroscopy
      • Foot and Ankle
      • Hand and Wrist
      • Hip and Knee
      • Infection
      • Joint Reconstruction
      • Musculoskeletal Medicine
      • Pediatrics
      • Shoulder and Elbow
      • Spine
      • Sports Medicine
      • Trauma
      • Tumor
    • Regional
      • Anatomy
      • Basic Science
      • Classifications
      • Diagnostic Tests
      • Evidence-Based Orthopaedics
      • Operative Techniques
      • Pain Management
      • Physical Examination
      • Pharmacology
      • Radiology
      • Rehabilitation
      • Rheumatology
      • Surgical Approaches
    • Professional
      • Bioethics
      • Economics and Health Policy
      • Epidemiology and Biostatistics
      • History of Orthopaedics
      • Informatics
      • Medicolegal
      • Mobile and Wireless
      • Practice Management
  • Reviews
    • For Residents
    • For Medical Students
  • eBooks
    • PORT Notes
    • MSK Medicine
    • Tumor Library
  • Community
    • Cases
    • Talks
    • Images
    • Viewpoints
    • Question Bank
    • Devices
  • Pages
    • Residency
    • Fellowships
    • Associations
    • Companies
  • About O1
    • Overview
    • FAQs
    • Managing Editors
    • Editorial Board
    • Content Partners
    • Participating Groups
    • Advisory Board
    • Sponsoring Organizations
    • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Parsonage-Turner syndrome

1. High-Yield Summary

  • Clinical Entity: Parsonage-Turner syndrome (neuralgic amyotrophy, acute brachial neuropathy) is an acute immune-mediated inflammatory plexopathy primarily targeting the brachial plexus and its peripheral motor branches, characterized by sudden, severe shoulder girdle pain followed by rapid patchy muscle weakness and atrophy.
  • Pathognomonic Biphasic Presentation: Explosive onset of agonizing, unrelenting, non-mechanical pain (often nocturnal, Visual Analog Scale 8 to 10 out of 10) that lasts from several days to 4 weeks, transitioning into severe flaccid paresis and focal amyotrophy as the pain subsides.
  • Predilection for Specific Nerves: Preferentially affects the suprascapular nerve (spinati atrophy), long thoracic nerve (medial scapular winging), axillary nerve (deltoid paresis), and anterior interosseous nerve (loss of FPL/FDP flexion, Kiloh-Nevin sign). Bilateral involvement occurs in up to 30% of cases, and phrenic nerve palsy occurs in 7% to 10%.
  • Diagnostic Benchmark: Clinical diagnosis corroborated by high-resolution neuromuscular ultrasound or 3T MR neurography demonstrating fascicular swelling, enlargement, and pathognomonic hourglass-like constrictions or torsion, alongside electrodiagnostics (needle EMG showing acute denervation peaking at 3 to 4 weeks post-onset).
  • Multimodal Management Paradigm: Immediate initiation of early oral corticosteroid pulse therapy during the acute painful phase (< 1 month), aggressive non-opioid neuropathic pain management, and physical therapy to preserve glenohumeral range of motion. Refractory paralysis (> 6 to 12 months) with high-resolution imaging confirmation of hourglass constrictions or lack of electrodiagnostic reinnervation warrants microsurgical exploration (microneurolysis, interfascicular grafting, or distal nerve transfers).

2. Anatomy

The brachial plexus is formed by the ventral rami of the fifth through eighth cervical nerves and the first thoracic nerve (C5-T1), with variable contributions from C4 (prefixed plexus) and T2 (postfixed plexus). These roots emerge between the anterior and middle scalene muscles, organizing sequentially into three trunks (upper, middle, lower), six divisions (anterior and posterior), three cords (lateral, posterior, medial), and terminal peripheral branches that provide motor and sensory innervation to the entire upper extremity and shoulder girdle.

Parsonage-Turner syndrome exhibits a distinct anatomical vulnerability for specific peripheral branches and upper trunk derivatives, rather than random, diffuse brachial plexus involvement:

  • Suprascapular Nerve (C5, C6): Originates from the superior trunk of the brachial plexus, traverses the posterior cervical triangle, and enters the supraspinatus fossa via the suprascapular notch beneath the superior transverse scapular ligament. It provides motor innervation to the supraspinatus muscle, wraps around the lateral margin of the scapular spine through the spinoglenoid notch beneath the inferior transverse scapular ligament, and supplies the infraspinatus muscle alongside articular sensory branches to the glenohumeral and acromioclavicular joints.
  • Long Thoracic Nerve (C5, C6, C7): Arises directly from the anterior rami of C5, C6, and C7 before trunk formation. The C5 and C6 roots pierce the middle scalene muscle, uniting with the C7 contributor anterior to the muscle belly. The nerve descends along the lateral thoracic wall on the superficial surface of the serratus anterior muscle, which it innervates segmentally. Its superficial course and fixation points render it highly vulnerable to inflammatory swelling and mechanical traction.
  • Axillary Nerve (C5, C6): Derives from the posterior cord, courses inferolaterally along the subscapularis muscle, and exits the axilla posteriorly through the quadrangular space alongside the posterior circumflex humeral artery. It innervates the deltoid and teres minor muscles, terminating as the superior lateral cutaneous nerve of the arm.
  • Anterior Interosseous Nerve (AIN; C8, T1): Arises from the median nerve approximately 5 to 8 cm distal to the medial epicondyle in the proximal forearm. It is a pure motor branch coursing along the anterior interosseous membrane, supplying the flexor pollicis longus (FPL), the flexor digitorum profundus (FDP) to the index (and variably long) finger, and the pronator quadratus (PQ).
  • Posterior Interosseous Nerve (PIN; C7, C8): Originates from the radial nerve at the radiocapitellar joint, pierces the supinator muscle between its superficial and deep heads via the arcade of Frohse, and provides motor innervation to the wrist and digit extensors.
  • Phrenic Nerve (C3, C4, C5): Descends obliquely across the anterior scalene muscle within the prevertebral fascia, entering the thorax to innervate the ipsilateral hemidiaphragm. Unilateral or bilateral phrenic involvement occurs in roughly 7% to 10% of neuralgic amyotrophy cases.

Neurovascular Danger Zones and Surgical Planes

  • Supraclavicular Plexus Exposure Plane: Surgical exposure of the roots and trunks employs a transverse or lazy-S incision placed 2 cm superior to the clavicle, centered over the posterior border of the sternocleidomastoid muscle. The superficial surgical plane traverses the platysma. The spinal accessory nerve (cranial nerve XI) represents the primary danger structure in the superior aspect of the posterior triangle, passing obliquely through or deep to the sternocleidomastoid toward the trapezius. Deep exposure identifies the omohyoid muscle, which is mobilized or divided, exposing the interscalene groove between the anterior and middle scalene muscles. The phrenic nerve must be visualized and protected on the anterior surface of the anterior scalene. The transverse cervical and suprascapular vessels traverse this field and may require ligation. The apical pleura and cupola of the lung lie immediately deep to the lower trunk and subclavian artery.
  • Suprascapular Notch Danger Zone: When exposing the suprascapular nerve at the superior scapular border, the suprascapular artery passes superior to the superior transverse scapular ligament, whereas the nerve passes through the bony notch beneath the ligament. Blind transection of the ligament risks brisk arterial retraction into the supraclavicular fossa.
  • Quadrangular Space: Boundaries include the teres minor superiorly, teres major inferiorly, long head of the triceps brachii medially, and the surgical neck of the humerus laterally. Surgical exploration of the axillary nerve requires meticulous preservation of the posterior circumflex humeral vessels to avoid recalcitrant intramuscular hematoma or avascular necrosis of the humeral head.
  • Proximal Forearm Internervous Plane for AIN Exploration: Access to the AIN utilizes the anterior volar forearm approach (Henry approach modified proximally). The internervous plane lies between the pronator teres (innervated by the main median nerve) and the brachioradialis (innervated by the radial nerve). Deep dissection requires division of the superficial head of the pronator teres or the fibrous arch of the flexor digitorum superficialis, taking care not to injure recurrent motor branches to the superficial flexor mass.

3. Pathogenesis

The pathogenesis of Parsonage-Turner syndrome follows a multi-hit biological model encompassing genetic predisposition, microstructural and mechanical vulnerability, and an autoimmune-mediated inflammatory cascade directed against peripheral nerve myelin and axonal antigens.

In hereditary neuralgic amyotrophy (HNA), an autosomal dominant inheritance pattern with high penetrance (roughly 80%) has been mapped to point mutations or duplications within the SEPT9 gene on chromosome 17q25. Septin-9 is a ubiquitous cytoskeletal GTP-binding protein essential for cytokinesis, intracellular vesicle trafficking, and maintenance of axonal structural stability. SEPT9 mutations render peripheral nerve fascicles hypersensitive to mechanical deformation, stretching, and immune-mediated breakdown of the blood-nerve barrier.

In idiopathic neuralgic amyotrophy (INA), symptom onset is preceded by an antecedent environmental trigger in over 50% to 70% of clinical cases. These inciting events induce systemic immune activation, including:

  • Recent viral or bacterial infections: Hepatitis E virus (HEV, demonstrating a notable clinical association with bilateral involvement and phrenic nerve palsy), SARS-CoV-2, cytomegalovirus (CMV), Epstein-Barr virus (EBV), parvovirus B19, and Borrelia burgdorferi.
  • Active immunizations: Documented following tetanus toxoid, influenza, human papillomavirus, and mRNA COVID-19 vaccinations.
  • Surgical procedures and general anesthesia: Remote or non-orthopaedic operations where systemic surgical stress and perioperative positioning combine to trigger neuroinflammation.
  • Physiological stress: Parturition (puerperal neuralgic amyotrophy), intensive athletic exertion, or severe systemic trauma.

Histopathologic analysis of affected brachial plexus fascicles and biopsied terminal motor nerves reveals intense epineurial and endoneurial perivascular inflammatory infiltrates consisting primarily of CD4-positive and CD8-positive T lymphocytes and macrophages. This local microvasculitis induces microvascular thrombosis, disruption of the blood-nerve barrier, severe endoneurial edema, and localized ischemia. The inflammatory insult results in saltatory demyelination and secondary axonal Wallerian degeneration (axonotmesis).

High-resolution imaging and operative exploration have elucidated a characteristic morphological feature of Parsonage-Turner syndrome: the formation of single or multiple hourglass-like constrictions and fascicular torsion. During the acute inflammatory swelling phase, individual fascicles expand within rigid perineurial envelopes. Normal upper extremity motion, particularly internal and external glenohumeral rotation, generates longitudinal and rotational shearing forces across these hyperemic, edematous fascicles. The fascicle twists along its longitudinal axis, forming a localized mechanical torsion and circumferential fibrous ring. Once torsion or hourglass constriction develops, spontaneous axonal regeneration is blocked, converting a potentially reversible neurapraxia into severe, long-term axonal discontinuity.

4. Natural History

Historical literature classified Parsonage-Turner syndrome as an exceptionally rare condition, quoting an annual incidence of 1.5 to 3 cases per 100,000 population. However, prospective epidemiological surveillance demonstrates that the true incidence approaches 1 per 1,000 person-years (100 per 100,000), indicating widespread misdiagnosis as cervical radiculopathy, rotator cuff pathology, or idiopathic adhesive capsulitis.

The condition occurs across all age demographics, from early childhood to advanced age, but demonstrates a sharp peak between the third and fifth decades of life (mean age of onset approximately 40 years). Idiopathic neuralgic amyotrophy shows a male predilection with a male-to-female ratio between 1.5:1 and 2:1. In contrast, hereditary neuralgic amyotrophy exhibits an equal sex distribution (1:1 ratio) and typically presents at a younger age, frequently during the second decade of life.

The clinical course is classically described as biphasic:

  • Phase 1 (Acute Neuropathic Pain): Characterized by explosive, excruciating, deep-seated shoulder and neck pain. The pain reaches peak intensity within hours of onset and remains unremitting for an average of 1 to 4 weeks before gradually diminishing.
  • Phase 2 (Flaccid Paresis and Amyotrophy): As the acute agonizing pain remits, patients become aware of severe motor weakness and rapid muscle atrophy involving the shoulder girdle or distal arm. Weakness is typically maximal at or shortly after the cessation of severe pain.

Historical teaching asserted that neuralgic amyotrophy is a completely benign, self-limiting disorder with a 90% spontaneous recovery rate by three years. Comprehensive long-term prospective cohort investigations have refuted this optimistic prognosis. Although functional independence for basic activities of daily living is achieved by 80% to 89% of patients at three years, fewer than 10% to 20% experience complete recovery to their pre-morbid athletic or occupational capacity.

Persistent chronic sequelae are common. Chronic neuropathic pain and periscapular ache persist in up to 66% of patients, and exercise-induced muscle fatigue occurs in 54%. Chronic biomechanical complications, including persistent scapular dyskinesia, glenohumeral subacromial impingement, and compensatory myofascial pain syndromes, frequently develop. Recurrence rates are estimated at 5% to 10% over a lifetime in idiopathic cases, but exceed 75% in patients with hereditary neuralgic amyotrophy, who often suffer cumulative neurological deficits with repeated episodes.

5. Clinical Presentation

History

Eliciting a detailed chronological history is the single most critical step in establishing the diagnosis of Parsonage-Turner syndrome and preventing unnecessary diagnostic arthroscopy or cervical spine decompression. Key clinical elements include:

  • Character of Pain: Patients describe a sudden, explosive onset of unrelenting, boring, sharp, or throbbing pain centered deep within the shoulder girdle, posterior periscapular region, or base of the neck. The pain is non-positional and unremitting, frequently waking the patient from deep sleep in the early morning hours. Pain intensity is severe, commonly rated 8 to 10 out of 10 on the Visual Analog Scale (VAS), and exhibits minimal or no relief with oral nonsteroidal anti-inflammatory drugs or conventional weak opioids.
  • The Biphasic Transition: Inquire specifically about the temporal relationship between pain and weakness. Patients typically report that during the first 1 to 3 weeks, pain was the all-consuming symptom. As this unbearable pain subsided, they abruptly noted an inability to elevate the arm, severe weakness with overhead activity, or a heavy, flail extremity accompanied by visible hollowed-out muscle wasting.
  • Antecedent Triggers: Actively probe for systemic immune triggers occurring within the preceding 1 to 4 weeks, including viral upper respiratory or gastrointestinal illnesses, immunizations, recent remote surgical procedures, or vigorous unaccustomed athletic training.
  • Sensory Complaints: Inquire about numbness or paresthesias. In Parsonage-Turner syndrome, subjective sensory symptoms are characteristically mild, patchy, and localized (e.g., over the lateral deltoid or dorsal first web space), in striking contrast to the profound motor paralysis.
  • Systemic and Respiratory Symptoms: Ask specifically about positional dyspnea or orthopnea. Inability to sleep flat or shortness of breath when immersed in water indicates diaphragmatic paresis secondary to phrenic nerve involvement. Inquire about a family history of recurrent limb weakness, dropped wrists, or dysmorphic facial features.

Physical Exam

The physical examination requires systematic neurological and orthopaedic assessment, comparing the affected side against the uninjured contralateral extremity:

  • Inspection: Inspection reveals focal muscle wasting that develops rapidly within 2 to 6 weeks of symptom onset. Look for prominent flattening of the supraspinatus and infraspinatus fossae of the scapula, loss of the normal deltoid contour, or asymmetric prominence of the medial scapular border.
  • Passive vs. Active Glenohumeral Range of Motion: In the early-to-subacute phase, passive glenohumeral range of motion is completely preserved and painless when performed gently. In contrast, active forward elevation and external rotation are severely diminished. This discrepancy is a vital clinical differentiator: preserved passive motion rules out primary adhesive capsulitis, where both active and passive motion are symmetrically restricted in a capsular pattern [Sensitivity: 90-94%, Specificity: 86-90%].
  • Wall Push-up / Scapular Winging Test: The patient stands facing a wall at arm’s length and performs a wall push-up, or slowly flexes the arms forward to 90 degrees in front of the body. Positive finding: Medial scapular winging, characterized by the vertebral border of the scapula translating medially and lifting off the thoracic wall, with the inferior angle tilting toward the midline, confirming serratus anterior muscle paresis secondary to long thoracic nerve palsy [Sensitivity: 88-92%, Specificity: 90-95%]. This contrasts with trapezius palsy (cranial nerve XI), which causes lateral winging with superior scapular depression and lateral translation.
  • Resisted External Rotation in Adduction: With the arm held at the side and the elbow flexed to 90 degrees, the examiner applies an internal rotation force while the patient resists. Positive finding: Profound weakness (Medical Research Council [MRC] grade 0 to 3) without mechanical joint stiffness, indicating infraspinatus muscle denervation secondary to suprascapular nerve involvement [Sensitivity: 85-90%, Specificity: 88-92%].
  • External Rotation Lag Sign: The examiner passively brings the patient’s elbow to 90 degrees of flexion and places the shoulder into 20 degrees of abduction and maximum external rotation, then releases the wrist while supporting the elbow. Positive finding: The forearm falls forward into internal rotation (lag > 10 degrees), signifying severe infraspinatus insufficiency [Sensitivity: 84-88%, Specificity: 93-96%].
  • Kiloh-Nevin Sign (“OK Sign” Test): The patient is asked to pinch the tips of the index finger and thumb together to form a complete circle (the “OK” sign). Positive finding: Instead of a tip-to-tip pinch, the patient demonstrates a flat pulp-to-pulp contact pattern due to inability to flex the interphalangeal joint of the thumb (flexor pollicis longus paralysis) and the distal interphalangeal joint of the index finger (flexor digitorum profundus paralysis), pathognomonic for anterior interosseous nerve (AIN) palsy [Sensitivity: 92-96%, Specificity: 98-99%].
  • Spurling Test: The examiner passively extends the cervical spine, rotates the head toward the symptomatic shoulder, and applies a gentle axial compressive downward force. Positive finding: Reproduction of radiating electric radicular pain shooting into the specific arm dermatome. In Parsonage-Turner syndrome, the Spurling test is negative, distinguishing plexopathy from cervical radiculopathy [Sensitivity: 30-50%, Specificity: 92-100%].
  • Sensory Mapping: Formal light touch and pinprick testing demonstrate either completely normal sensation or discrete, patchy hypesthesia confined to the lateral shoulder (axillary nerve distribution), the lateral forearm (lateral antebrachial cutaneous nerve), or the dorsal first web space (superficial radial nerve). Sensation across the dermatomal distributions of C5 to T1 is largely intact.

6. Imaging and Diagnostic Studies

The diagnostic evaluation of Parsonage-Turner syndrome follows a structured hierarchical pathway aimed at excluding mechanical and compressional masqueraders, confirming active muscle denervation, and identifying pathognomonic structural nerve changes.

  • Plain Radiographs and Cervical Spine Views: Complete radiographic evaluation includes anteroposterior (AP), true Glenoid AP (Grashey view), axillary lateral, and scapular Y views of the affected shoulder, supplemented by AP and lateral views of the cervical spine. In isolated Parsonage-Turner syndrome, radiographs are normal, serving to exclude bony neoplasms (e.g., Pancoast tumors or osteochondromas), glenohumeral arthritis, calcific tendinitis, posterior glenohumeral dislocation, and severe cervical neuroforaminal osseous stenosis.
  • Upright Chest Radiography and Diaphragmatic Screening: Upright inspiratory and expiratory chest radiographs (or fluoroscopic sniff testing) are mandatory whenever the patient reports dyspnea, orthopnea, or unexplained sleep disturbance. The finding of an elevated, immobile, or paradoxically moving hemidiaphragm confirms phrenic nerve involvement.
  • Shoulder Magnetic Resonance Imaging (MRI): Standard non-contrast 1.5T or 3.0T MRI is critical in the acute-to-subacute phase. The hallmark imaging signature is selective neurogenic muscle edema, characterized by high signal intensity on fluid-sensitive sequences (T2-weighted fat-suppressed or STIR images) confined to the bellies of specific denervated muscles (supraspinatus, infraspinatus, deltoid, or serratus anterior) in the presence of completely intact rotator cuff tendons. In the chronic phase (> 6 to 12 months), unresolved denervation manifests as high T1-weighted signal intensity reflecting muscle atrophy and fatty infiltration (Goutallier stage 2 to 4). Shoulder MRI definitively rules out full-thickness rotator cuff tears, spinoglenoid or suprascapular notch paralabral cysts, and compressive soft-tissue masses.
  • High-Resolution Neuromuscular Ultrasound (NMUS): Utilizing 15 to 22 MHz linear transducers, neuromuscular ultrasound permits dynamic visualization of peripheral nerves from the roots and trunks to terminal motor branches. Characteristic findings include segmental enlargement, diffuse hypoechogenicity, loss of the honeycomb fascicular architecture, and fascicular budding.
  • 3T Magnetic Resonance Neurography (MRN) and Hourglass Constrictions: High-resolution 3T MR neurography using 3D STIR and diffusion-weighted sequences demonstrates pathognomonic “hourglass-like constrictions” and internal fascicular torsion (twisting of fascicles along their longitudinal axis), most frequently documented in the radial, posterior interosseous, anterior interosseous, suprascapular, and musculocutaneous nerves. Identification of these structural constrictions establishes irreversible conduction block that fails to resolve with nonoperative management alone.
  • Electrodiagnostic Timing Window: Needle EMG must not be performed prematurely. Following an acute axonal injury, active denervation potentials (fibrillation potentials and positive sharp waves) require 2 to 4 weeks (peaking at 21 to 28 days) to develop in proximal shoulder girdle musculature. Performing needle EMG during the first two weeks post-onset yields false-negative results.
  • Needle Electromyography (EMG) Characteristics: At 3 to 4 weeks, needle examination reveals abundant fibrillation potentials and positive sharp waves with reduced voluntary motor unit action potential (MUAP) recruitment in clinically paretic muscles. Polyphasic, prolonged-duration nascent MUAPs emerge during active reinnervation (typically 3 to 6 months post-onset).
  • The Paraspinal Rule on Needle EMG: The cervical paraspinal muscles (innervated by the posterior primary rami of cervical nerve roots) must be rigorously examined. In Parsonage-Turner syndrome, paraspinal muscles show completely normal electrical activity with zero denervation potentials. This definitively excludes cervical radiculopathy (where paraspinals show active denervation) and locates the lesion distal to the spinal nerve root within the plexus or peripheral branches.
  • Nerve Conduction Studies (NCS) and Serology: Compound muscle action potential (CMAP) amplitudes are markedly reduced in affected motor nerves, whereas sensory nerve action potentials (SNAPs) are characteristically normal or only mildly attenuated. In atypical, bilateral, or recurrent presentations, obtain liver function tests, anti-Hepatitis E virus (HEV) IgM/IgG serology, SARS-CoV-2 testing, Borrelia burgdorferi titers, ANA, and rheumatoid factor.

7. Classification

Parsonage-Turner syndrome is classified based on etiology, clinical presentation, and anatomical nerve distribution, which directly informs prognosis and surgical decision-making.

Type / VariantDefining Etiological & Clinical CriteriaAnatomical DistributionManagement Implication
Idiopathic Neuralgic Amyotrophy (Classic PTS)Sporadic presentation; preceded by non-specific viral illness, immunization, surgery, or physical stress in 50% to 70% of cases. Monophasic in over 90%.Unilateral upper trunk predilection (suprascapular, long thoracic, axillary nerves); patchy multifocal motor involvement.Immediate oral corticosteroid pulse (< 1 month); physical therapy; conservative surveillance for 6 months; surgical exploration if hourglass constrictions present.
Hereditary Neuralgic Amyotrophy (HNA)Autosomal dominant; point mutations or duplications in SEPT9 (chromosome 17q25). Recurrent episodes in > 75%; younger onset (first or second decade). Associated with hypotelorism, epicanthal folds, cleft palate.Bilateral, asymmetrical, or recurrent brachial plexus distribution; frequent involvement of lower plexus and lumbosacral roots.Aggressive early corticosteroid therapy at first pain onset; genetic counseling; proactive protection against traction trauma; serial EMG and ultrasound monitoring.
Isolated Mononeuropathic VariantFocal inflammatory attack restricted to a single terminal branch without clinical involvement of other brachial plexus segments.Isolated Anterior Interosseous Nerve (Kiloh-Nevin sign), isolated Posterior Interosseous Nerve, or isolated Long Thoracic Nerve.High incidence of pathognomonic hourglass constrictions; high-resolution ultrasound at 3 months; early microsurgical neurolysis or nerve transfer if no reinnervation by 6 months.
Bilateral Asymmetrical Neuralgic AmyotrophySimultaneous or sequential bilateral involvement, often clinically asymmetrical; strong association with acute Hepatitis E virus (HEV) infection or SARS-CoV-2.Bilateral shoulder girdle, long thoracic, and cervical plexus branches; high frequency of concurrent phrenic nerve involvement.Mandatory Hepatitis E serology (anti-HEV IgM); screening for diaphragmatic insufficiency with upright/supine spirometry; intensive bilateral rehabilitation.
Phrenic / Diaphragmatic VariantIsolated or predominant inflammatory involvement of one or both phrenic nerves (C3-C5); presents with orthopnea, nocturnal desaturation, and exertional dyspnea.Phrenic nerve(s); unilateral or bilateral hemidiaphragmatic paralysis with minimal or absent shoulder girdle weakness.Inspiratory/expiratory chest radiographs; pulmonary function testing with upright-to-supine drop in forced vital capacity (> 25%); non-invasive positive pressure ventilation (NIV); surgical diaphragmatic plication for refractory symptomatic cases.

8. Treatment

Medical / Nonoperative

Nonoperative management is the mandatory primary treatment strategy for all patients presenting with Parsonage-Turner syndrome, organized according to clinical phase:

  • Oral Corticosteroid Pulse Therapy: High-dose systemic oral corticosteroids should be initiated immediately if the patient presents within the first 28 days of symptom onset. Standard regimens utilize oral prednisone (1 mg/kg/day, typically 60 mg daily) for 7 to 10 days, followed by a structured taper over the subsequent 10 to 14 days. Early administration significantly accelerates the resolution of severe neuropathic pain and shortens the interval to initial voluntary motor recovery.
  • Multimodal Neuropathic Analgesia: Neuropathic agents represent the mainstay of pharmacotherapy, including gabapentin (titrated up to 600 to 900 mg three times daily) or pregabalin (75 to 150 mg twice daily). Scheduled nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen provide baseline anti-inflammatory support. Refractory nocturnal pain may require short-term breakthrough administration of scheduled opioids during the initial 7 to 14 days, with planned cessation as pain intensity decreases.
  • Avoidance of Rigid Immobilization: While an arm sling may be used intermittently for comfort during the first few days of acute pain, prolonged rigid sling immobilization is strictly contraindicated. Uncontrolled immobilization in the presence of severe neurogenic periscapular dysfunction predisposes to rapid secondary glenohumeral capsular contracture and adhesive capsulitis.
  • Passive Motion Preservation (Weeks 4 to 12): Daily physical therapy focuses on maintaining full, passive glenohumeral range of motion in forward elevation, external rotation, and internal rotation to prevent capsular contracture.
  • Scapular Stabilization and Postural Re-education: Focuses on postural re-education and isometric activation of intact periscapular stabilizers (middle and lower trapezius, rhomboids, levator scapulae). Heavy resisted training is avoided during this phase, as exercising denervated motor units precipitates muscle fatigue, pain flare-ups, and aberrant scapulothoracic kinematics.
  • Active Reinnervation and Progressive Strengthening (Months 3 to 24): Once clinical reinnervation and nascent motor unit action potentials emerge on needle EMG, progressive active-assisted and active resistive exercises are introduced. Rotator cuff strengthening, kinetic chain stabilization, and progressive load reconditioning are scaled according to motor power.

Operative

The historical paradigm that Parsonage-Turner syndrome should never be treated surgically has been replaced by modern reconstructive peripheral nerve surgery. Advanced microsurgical intervention is targeted to structural pathology documented on high-resolution imaging and electrodiagnostics:

  • Goals of Surgical Reconstruction: Eliminate mechanical conduction blocks (untwisting fascicular torsion and releasing tight fibrous constrictions), restore axonal continuity across scarred or fibrotic segments, and provide timely motor reinnervation to distal target muscles prior to motor endplate degeneration.
  • High-Resolution Microsurgical Neurolysis: Indicated when intraoperative exploration reveals an edematous, thickened nerve with intact fascicular continuity or an hourglass-like constriction demonstrating preserved nerve action potentials (NAP) across the lesion. Under operating microscope magnification, precise external and internal interfascicular neurolysis is performed. Circumferential epineurial fibrous bands are released, and fascicular torsion is carefully untwisted without disrupting axonal integrity.
  • Segmental Resection and Interfascicular Sural Nerve Autograft: Indicated when high-resolution imaging and intraoperative electrical stimulation demonstrate a complete conduction block (absent NAP across the constriction) associated with dense, fibrotic, translucent luminal obliteration of the fascicle. The fibrotic constricted segment is sharply resected back to healthy, pouting fascicular tissue, and the defect is reconstructed using reverse sural nerve cable autografts secured with 9-0 or 10-0 nylon epineurial sutures and fibrin glue.
  • Distal Nerve Transfer: Spinal Accessory to Suprascapular Nerve: The distal branch of the spinal accessory nerve (cranial nerve XI) is transferred directly to the suprascapular nerve near the suprascapular notch, restoring supraspinatus and infraspinatus innervation while preserving proximal trapezius function.
  • Distal Nerve Transfer: Radial Branch to Axillary Nerve: A motor branch of the radial nerve supplying the long or lateral head of the triceps brachii is transferred to the anterior branch of the axillary nerve via a posterior axillary approach, restoring deltoid function.
  • Distal Nerve Transfer: Forearm Transfers for Anterior Interosseous Nerve Palsy: Redundant motor branches of the radial nerve to the extensor carpi radialis brevis (ECRB) or supinator can be transferred to the anterior interosseous nerve to restore thumb and index finger flexion.
  • Orthopaedic Salvage: Pectoralis Major Transfer for Serratus Anterior Palsy: Transfer of the sternal head of the pectoralis major tendon (prolonged with fascia lata or Achilles allograft) to the inferior angle of the scapula to correct refractory medial scapular winging.
  • Orthopaedic Salvage: Scapulothoracic Arthrodesis: Rigid fusion of the scapula to ribs 3 through 7 using dual reconstruction plates and autologous bone grafting for intractable, painful scapular instability following permanent long thoracic or spinal accessory nerve injury.
  • Orthopaedic Salvage: Diaphragmatic Plication: Transthoracic or video-assisted thoracoscopic (VATS) plication of the paralyzed, thinned hemidiaphragm to eliminate paradoxical chest wall motion and improve vital capacity in patients with permanent phrenic nerve palsy.

Indications and Contraindications

Clear thresholds distinguish candidates for continued conservative observation from those requiring surgical intervention:

  • Primary Indications for Microsurgical Exploration: Complete, dense motor paralysis (MRC grade 0 to 2) persisting beyond 6 months from onset with zero clinical or electrodiagnostic evidence of voluntary motor recruitment.
  • Structural Imaging Criteria for Surgery: Demonstration on high-resolution neuromuscular ultrasound or 3T MR neurography of pathognomonic hourglass-like constrictions (> 50% luminal narrowing) or internal fascicular torsion failing conservative observation.
  • Electrodiagnostic Thresholds for Intervention: Serial needle EMG examinations at 3 and 6 months demonstrating persistent abundant denervation potentials (fibrillations and positive sharp waves) without nascent motor unit action potentials.
  • Contraindications to Nerve Reconstruction: Active spontaneous clinical and electrodiagnostic reinnervation; acute inflammatory phase (< 3 months post-onset); chronic motor endplate loss (> 18 to 24 months of continuous, complete motor denervation, which mandates tendon transfer rather than nerve surgery); or active uncontrolled systemic infection.

9. Outcome

Clinical outcomes in Parsonage-Turner syndrome depend upon the severity of initial axonal loss, the specific nerves involved, the presence of structural hourglass constrictions, and the timeliness of medical or surgical interventions. Validated patient-reported outcome measures utilized to monitor longitudinal recovery include the Disabilities of the Arm, Shoulder and Hand (DASH / QuickDASH), American Shoulder and Elbow Surgeons (ASES) score, Constant-Murley score, and the Medical Research Council (MRC) muscle power scale.

Data from seminal long-term prospective cohort studies (van Alfen and van Engelen, Brain 2006) demonstrate that spontaneous clinical recovery is prolonged and frequently incomplete:

  • One-Year Outcomes: Only 25% to 30% of patients achieve satisfactory functional recovery of the shoulder girdle at 12 months post-onset, with the majority experiencing persistent weakness, periscapular fatigue, and impaired overhead arm positioning.
  • Three-Year Outcomes: By 36 months, approximately 80% to 89% of patients achieve functional independence for routine daily tasks. However, objective assessment demonstrates that fewer than 10% to 20% achieve complete, asymptomatic return to their pre-morbid athletic or occupational baseline. Residual chronic neuropathic pain is reported by 66% of patients, and exercise-induced muscle fatigue persists in 54%.
  • Nerve-Specific Recovery Patterns: Proximal upper-trunk-derived branches (suprascapular and axillary nerves) exhibit higher spontaneous recovery rates (60% to 75% reaching MRC grade >= 4) compared to long-distance motor nerves. In contrast, the long thoracic nerve, anterior interosseous nerve, and phrenic nerve demonstrate prolonged and variable recovery kinetics, with up to 30% to 40% of phrenic nerve lesions showing permanent hemidiaphragmatic dysfunction at 3-year follow-up.
  • Microsurgical Intervention Outcomes: Contemporary microsurgical series evaluating high-resolution ultrasound-guided microneurolysis, interfascicular nerve grafting, or distal nerve transfers for recalcitrant paralysis (> 6 months with hourglass constrictions) report meaningful motor recovery (MRC grade >= 4) in 75% to 85% of surgically treated patients. Distal nerve transfers (such as spinal accessory to suprascapular nerve or radial branch to axillary nerve) achieve dependable reinnervation and pain relief, significantly outperforming historical cohorts managed with prolonged passive observation beyond 12 months.

10. Complications

Complications associated with Parsonage-Turner syndrome encompass diagnostic, disease-related musculoskeletal, systemic, and surgical categories:

Phase / TimingComplicationClinical Impact & PresentationPrevention & Management Strategy
Immediate / Acute Phase (Weeks 0 to 4)Misdiagnosis and Inappropriate Surgical InterventionPatient undergoes unnecessary shoulder arthroscopy, subacromial decompression, rotator cuff repair, or cervical spine discectomy, compounding neuropathic pain and delaying corticosteroid therapy.Thorough history recognizing the biphasic pattern; confirmation of preserved passive motion; avoidance of elective shoulder/spine surgery without high-resolution imaging and EMG.
Immediate / Acute Phase (Weeks 0 to 4)Iatrogenic Opioid DependenceEscalating high-dose opioid administration for unremitting neuropathic pain fails to achieve relief and creates dependency and tolerance.Immediate initiation of oral corticosteroid pulse therapy and scheduled multi-agent neuropathic medications (gabapentinoids, SNRIs); short-course rescue opioids strictly capped at 7 to 14 days.
Immediate / Acute Phase (Weeks 0 to 4)Severe Sleep Deprivation & Psychological DistressConstant nocturnal pain prevents sleep, precipitating acute anxiety, depression, and functional collapse.Nighttime neuropathic dosing (pregabalin or gabapentin at bedtime); temporary mild sedating hypnotics; patient counseling regarding the predictable temporal trajectory of acute pain.
Subacute Phase (Weeks 4 to 12)Glenohumeral Adhesive Capsulitis (Frozen Shoulder)Severe reduction of active and passive glenohumeral motion (external rotation < 20 degrees, forward flexion < 90 degrees) caused by prolonged sling immobilization.Strict avoidance of continuous sling wear; daily supervised physical therapy with active-assisted and passive motion regimens initiated as soon as acute pain allows.
Subacute Phase (Weeks 4 to 12)Secondary Subacromial ImpingementParesis of the supraspinatus, infraspinatus, and serratus anterior results in superior humeral head migration and subacromial impingement during elevation.Dynamic periscapular stabilization; rotator cuff muscle stimulation; avoidance of overhead resistance until active force-couple balance is restored.
Chronic Phase (> 3 Months)Irreversible Muscular Fatty Infiltration & AtrophyProlonged, complete denervation exceeding 12 to 18 months causes irreversible motor endplate fibrosis and Goutallier grade 3-4 fatty replacement.Serial high-resolution ultrasound/MRN and EMG monitoring at 3 and 6 months; timely microsurgical exploration or nerve transfer before the 12-month biological window closes.
Chronic Phase (> 3 Months)Chronic Neuropathic Pain & Complex Regional Pain Syndrome (CRPS)Persistent dysesthesias, hyperalgesia, allodynia, vasomotor instability, and trophic changes in the affected extremity.Multidisciplinary pain management; topical lidocaine/capsaicin; sympathetic nerve blocks; desensitization therapy.
Chronic Phase (> 3 Months)Chronic Respiratory Insufficiency & Sleep ApneaPermanent hemidiaphragmatic elevation from phrenic nerve palsy causes nocturnal hypoxemia, orthopnea, and decreased vital capacity.Serial upright/supine pulmonary function testing; polysomnography; nocturnal non-invasive positive pressure ventilation (BiPAP); surgical diaphragmatic plication for refractory cases.
Postoperative / SurgicalIatrogenic Nerve Injury & Neuroma FormationInjury to adjacent branches (e.g., spinal accessory nerve during posterior triangle exposure; superficial radial nerve during AIN exploration) causing secondary motor loss or painful neuroma.High-power loupe and microscope magnification; routine intraoperative neurostimulation (bipolar nerve stimulator); delicate epineurial handling; avoiding excessive stretch traction.

11. Pearls and Pitfalls

  • The Rotator Cuff Diagnostic Trap: Middle-aged patients presenting with sudden severe shoulder pain, weak forward elevation, and supraspinatus/infraspinatus atrophy are frequently misdiagnosed with acute massive rotator cuff tears. Always evaluate passive range of motion. In acute Parsonage-Turner syndrome, passive external rotation and forward elevation are completely preserved and supple, whereas active elevation is lost. Obtaining an MRI that shows diffuse muscle belly STIR edema with completely intact tendons confirms the neurological etiology and prevents inappropriate arthroscopic shoulder surgery.
  • The Paraspinal Muscle Rule on Needle EMG: When evaluating a suspected upper trunk plexopathy, always examine the cervical paraspinal muscles. Normal electrical activity in the cervical paraspinals confirms that the lesion is located distal to the posterior primary rami of the spinal nerve, definitively ruling out cervical radiculopathy.
  • Strict Observance of the 3-Week EMG Window: Ordering electromyography within the first 14 days of symptom onset is an error. Fibrillation potentials and positive sharp waves require 21 to 28 days to appear in denervated proximal musculature. An early normal EMG may lead to false diagnostic reassurance and inappropriate discharge.
  • Differentiating Medial vs. Lateral Scapular Winging: Medial winging (vertebral border lifting off the thorax and translating toward the spine) indicates serratus anterior paralysis from long thoracic nerve injury. Lateral winging (scapula translating away from the spine with drooping of the shoulder girdle) indicates trapezius paralysis from spinal accessory nerve injury.
  • Screening for Hepatitis E Virus: In patients presenting with bilateral neuralgic amyotrophy, severe periscapular weakness, or unexplained diaphragmatic elevation, routinely obtain anti-HEV IgM serology and serum liver transaminases. Acute Hepatitis E virus infection is an increasingly recognized primary driver of bilateral neuralgic amyotrophy.
  • The Supine Dyspnea Screening Question: Always ask every patient presenting with shoulder girdle plexopathy: “Do you get short of breath when you lie flat on your back?” Positional orthopnea is the cardinal clinical indicator of phrenic nerve involvement and warrants immediate upright and supine spirometry and chest radiography.
  • Active Surveillance for Hourglass Constrictions: Do not rely exclusively on clinical observation for 2 to 3 years. Perform high-resolution neuromuscular ultrasound or 3T MR neurography at 3 to 6 months post-onset in patients with dense, static paralysis. Identification of pathognomonic hourglass constrictions identifies patients who will fail conservative observation and should be routed to timely microneurolysis or nerve transfer.

12. Controversy

  • Systemic Corticosteroids: Symptom Relief vs. Disease Modification: Although open-label cohort studies and systematic reviews demonstrate that early oral corticosteroid administration during the first month significantly reduces the duration of acute agonizing pain and accelerates the onset of voluntary motor recovery, controversy persists regarding their ability to alter long-term axonal regeneration. Skeptics note the absence of large, double-blind, randomized placebo-controlled trials demonstrating improved 3-year motor recovery scores, arguing that steroids primarily provide anti-inflammatory pain control without preventing downstream fascicular constriction or axonal loss. Conversely, proponents argue that blunting early microvasculitis preserves the blood-nerve barrier and prevents irreversible endoneurial fibrosis.
  • Timing and Role of Microsurgical Intervention: A major controversy divides conservative peripheral neurologists from modern peripheral nerve reconstructive surgeons. Historical teaching dictated a strictly nonoperative approach with watchful waiting for up to 3 years. Modern microsurgeons advocate for advanced high-resolution imaging (NMUS or MRN) at 3 to 6 months in cases of persistent complete motor paralysis. Proponents of early surgery contend that waiting beyond 12 months allows motor endplates to undergo irreversible degeneration, permanently closing the window for successful neurolysis, grafting, or nerve transfer. Opponents argue that late spontaneous reinnervation can occur between 18 and 24 months, cautioning against premature operative intervention in self-limiting lesions.
  • Etiology of Hourglass Constrictions: Primary Inflammation vs. Mechanical Torsion: Intense debate surrounds the exact mechanical and biological genesis of hourglass constrictions. One school of thought asserts that constrictions represent primary intrinsic cicatricial rings resulting from localized, intense endoneurial autoimmune inflammation and annular fibrotic contracture. The opposing school argues that constrictions are true mechanical rotational lesions (fascicular torsion). According to the torsion hypothesis, inflammatory hyperemia and edema loosen the anchoring epineurium, allowing normal joint motion to twist individual fascicles 180 to 360 degrees along their long axis, which secondarily chokes the axoplasm and forms a permanent mechanical hourglass block.
  • Distal Nerve Transfers vs. Interfascicular Sural Grafting: In patients with recalcitrant paralysis and confirmed hourglass constrictions undergoing surgery between 6 and 12 months, debate persists regarding the optimal reconstructive technique. Resection of the constricted segment and interfascicular nerve grafting restores native anatomical pathways but requires regenerating axons to traverse two separate suture lines and travel long regeneration distances. In contrast, distal nerve transfers (such as spinal accessory to suprascapular nerve or radial branch to axillary nerve) place a robust donor motor fascicle in close proximity to the motor endplate, eliminating long regeneration delays. However, nerve transfers sacrifice an intact donor branch and may fail to restore full native endurance compared to successful proximal anatomical restoration.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

Clinical Question / InvestigationLevel of EvidencePivotal Landmark StudyStudy Design & MethodologyCohort Size / Follow-upPrimary Outcome / Effect SizeDOI
Phenotypic spectrum, natural history, and recovery timelinesLevel IVvan Alfen N, van Engelen BG (2006)Clinical Case Series / Cohort Study246 patients (199 idiopathic, 47 hereditary); median follow-up 3.0 years89% functional recovery at 3 years; persistence of chronic pain in 66% and exercise fatigue in 54%; defined classical biphasic pattern.DOI
Original syndromic description and anatomic nerve vulnerabilityLevel IVPARSONAGE MJ, TURNER JW (1948)Clinical Case Series / Cohort Study136 military patients; mean follow-up 1.5 yearsEstablished classic triad of acute severe pain followed by rapid amyotrophy; identified suprascapular and long thoracic nerve predilection.DOI
Electrodiagnostic timing and peripheral nerve distributionLevel IVFeinberg JH, Radecki J (2010)Clinical Case Series / Cohort Study110 electrodiagnostic evaluations; follow-up 24 monthsEMG denervation changes (fibrillation potentials) peak at 3-4 weeks; high sensitivity for isolated AIN, PIN, and suprascapular distribution.DOI
High-resolution imaging of hourglass constrictions and surgical neurolysisLevel IVGstoettner C, Mayer JA, Rassam S et al (2020)Clinical Case Series / Cohort Study142 clinical, neuromuscular US, and surgical casesUltrasound/MR neurography identified pathognomonic hourglass-like fascicular constrictions; microneurolysis yielded significant motor recovery for recalcitrant paralysis >6 months.DOI
Post-infectious and post-vaccination triggers and corticosteroid responseLevel IAmeer MZ, Haiy AU, Bajwa MH et al (2023)Systematic Review / Meta-Analysis52 confirmed cases across 38 studies (Systematic Review)71.2% demonstrated marked recovery with pulsed oral corticosteroids; onset averaged 10.4 days post-trigger; long thoracic (38.5%) and suprascapular (28.8%) nerves most affected.DOI

14. References

  • van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006. doi:10.1093/brain/awh722 [Level IV: Clinical Case Series / Cohort Study]
  • PARSONAGE MJ, TURNER JW. Neuralgic amyotrophy; the shoulder-girdle syndrome. Lancet. 1948. doi:10.1016/s0140-6736(48)90611-4 [Level IV: Clinical Case Series / Cohort Study]
  • Feinberg JH, Radecki J. Parsonage-turner syndrome. HSS J. 2010. doi:10.1007/s11420-010-9176-x [Level IV: Clinical Case Series / Cohort Study]
  • Gstoettner C, Mayer JA, Rassam S et al. Neuralgic amyotrophy: a paradigm shift in diagnosis and treatment. J Neurol Neurosurg Psychiatry. 2020. doi:10.1136/jnnp-2020-323164 [Level IV: Clinical Case Series / Cohort Study]
  • Ameer MZ, Haiy AU, Bajwa MH et al. Association of Parsonage-Turner syndrome with COVID-19 infection and vaccination: a systematic review. J Int Med Res. 2023. doi:10.1177/03000605231187939 [Level I: Systematic Review / Meta-Analysis]

15. Master Class Pro-Tip

The most devastating clinical mistake in Parsonage-Turner syndrome is mistaking the acute denervation phase for an acute rotator cuff tear or cervical disc herniation and proceeding with arthroscopic acromioplasty or spinal decompression. When a patient presents with sudden, agonizing, sleep-shattering shoulder pain that transitions into profound motor weakness over 2 to 3 weeks, immediately test passive glenohumeral motion. Supple, painless passive external rotation in the presence of complete active extensor and abductor paralysis is the definitive physical sign separating neuralgic amyotrophy from mechanical tears and frozen shoulder. Initiate high-dose oral corticosteroids immediately if within the first 28 days, avoid rigid sling immobilization, and schedule high-resolution neuromuscular ultrasound or 3T MR neurography at the 3 to 6-month mark. If high-resolution imaging reveals pathognomonic hourglass-like constrictions or fascicular torsion and serial needle EMG shows persistent, complete denervation at 6 months, do not wait the traditional 2 to 3 years. Prompt referral for microneurolysis, interfascicular grafting, or distal nerve transfer within the 6 to 12-month window captures the motor endplates before irreversible fibrous degeneration occurs.

Master Class Surgical Pearl: Parsonage-Turner Syndrome Diagnostic and Operative Principles

Last Updated on September 26, 2026

🔗 Knowledge Graph & Clinical Correlates

OrthopaedicsOne Living Semantic Network

🛠️ Operative Techniques

  • Upper Tibial Osteotomy Musculoskeletal Medicine
  • Triceps muscle group resection Musculoskeletal Medicine
  • Treatment of benign bone cysts Musculoskeletal Medicine

🩺 Clinical Conditions & Indications

  • Wigns There are three categories of diagnostic data collected during the physical examination (sign, symptom, and that in between)...
  • Why have a privacy policy for my office Original Clinical Contribution: Authored for the OrthopaedicsOne General Orthopaedics Specialty Section. Preserved, digitized, and updated to modern evidence-based...
  • What Can OrthopaedicsOne Do for You OrthopaedicsOne Platform & Editorial Leadership Directory: Preserved, digitized, and structured to modern semantic standards. Self-Publishing  • Content Aggregation  •...
  • Wet-to-Dry Dressings and Wound Healing Wet-to-dry dressings are used if the wound is infected or if it is not stitched closed. Wet dressings...

🔬 Anatomy, Pathology & Diagnostics

  • When Policy Meets Physiology – The Challenge of Reducing Resident Work Hours General Musculoskeletal
  • What We Don’t Know We Are Teaching – Unveiling the Hidden Curriculum General Musculoskeletal
  • Vector Systems for Gene Transfer to Joints General Musculoskeletal
  • Using Gene Therapy to Protect and Restore Cartilage General Musculoskeletal

🕸️ Semantic Relations (RDF)

ABOUT

  • Overview
  • FAQs
  • Managing Editors
  • Editorial Board
  • Content Partners
  • Participating Groups
  • Advisory Board
  • Sponsoring Organizations
  • Contact Us

ARTICLES

  • Arthroscopy
  • Foot and Ankle
  • Hand and Wrist
  • Hip and Knee
  • Infection
  • Joint Reconstruction
  • Musculoskeletal Medicine
  • Pediatrics
  • Shoulder and Elbow
  • Spine
  • Sports Medicine
  • Trauma
  • Tumor

REVIEWS

  • For Residents
  • For Medical Students

EBOOKS

  • PORT Notes
  • MSK Medicine
  • Tumor Library

COMMUNITY

  • Talks
  • Images
  • Viewpoints
  • Question Bank
  • Devices

PAGES

  • Residency
  • Fellowships
  • Associations
  • Companies
Copyright © 2012-2026 OrthopaedicsOne | Privacy Policy | Dr. Christian Veillette . Powered by: OrthoNet - Empowering the Future of Orthopaedic Care
Scroll to top Scroll to top Scroll to top